摘要
目的探讨益智宁神口服液联合小儿智力糖浆治疗儿童多动症的临床效果。方法将我院于2014年5月至2015年7月期间救治的142例儿童多动症患者随机分成研究组和对照组,对照组采用利他林治疗,研究组采用益智宁神口服液联合小儿智力糖浆治疗,治疗周期为2个月。对比两组患者的临床疗效、Conner行为评定量表评分及不良反应。结果研究组患者的总有效率明显高于对照组(P<0.01),Conner行为评定量表各因子评分均明显优于对照组(P<0.01),不良反应发生率显著低于对照组(P<0.05)。结论益智宁神口服液联合小儿智力糖浆在小儿多动症的治疗中具有良好的有效性和安全性,值得临床推广应用。
Objective To explore the curative effect of Yizhi Ningshen oral liquid combined with infantile zhili syrup in the treatment of attention deficit hyperacticity disorder. Methods 142 cases of hospitalized attention deficit hyperacticity disorder patients our hospital from May 2014 to July 2015 were divided into research group and control group,patients in control group were treated with ritalin,while those in research group was cured with Yizhi Ningshen oral liquid combined with infantile zhili syrup. After 2 months of treatment duration,compare the clinical effect,Conner behavior rating scale scores and side effect of these two groups. Results The clinical total effective rate of research group was significantly higher than control group（ P〈0. 01）,all single Conner behavior rating scale scores were significantly better than control group（ P〈0. 01）,side effect incidence rate was considerably lower than control group（ P〈0. 05）. Conclusion Yizhi Ningshen oral liquid combined with infantile zhili syrup have good validity and safety in the treatment of attention deficit hyperacticity disorder,and thus worth to be popularized.
出处
《国际精神病学杂志》
2016年第1期106-109,共4页
Journal Of International Psychiatry
基金
江苏省卫生厅科技计划资助项目(项目编号:H200823)
关键词
益智宁神口服液
小儿智力糖浆
儿童多动症
安全性
Yizhi Ningshen oral liquid
Infantile zhili syrup
Attention deficit hyperacticity disorder
Safety
